{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T04:27:43Z","timestamp":1787372863530,"version":"build-2736575974"},"reference-count":10,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.7631-26","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T22:10:59Z","timestamp":1787091059000},"source":"Crossref","is-referenced-by-count":0,"title":["Follicular Lymphoma Involving the Supraglottic Larynx in a Patient with Recurrent Cutaneous B-cell Lymphoproliferative Lesions: A Case Report"],"prefix":"10.2169","author":[{"given":"Ryohei","family":"Asai","sequence":"first","affiliation":[{"name":"Department of Otolaryngology-Head and Neck Surgery, Nihon University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroumi","family":"Matsuzaki","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology-Head and Neck Surgery, Nihon University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimon","family":"Otake","sequence":"additional","affiliation":[{"name":"Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tang","family":"Xiaoyan","sequence":"additional","affiliation":[{"name":"Division of Oncologic Pathology, Department of Pathology and Microbiology, Nihon University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Oshima","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology-Head and Neck Surgery, Nihon University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Markou K, Goudakos J, Constantinidis J, et al. Primary laryngeal lymphoma: report of 3 cases and review of the literature. Head Neck 32:541-549, 2010.","DOI":"10.1002\/hed.21104"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ansell SM, Habermann TM, Hoyer JD, et al. Primary laryngeal lymphoma. Laryngoscope 107:1502-1506, 1997.","DOI":"10.1097\/00005537-199711000-00014"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kim KH, Kim RB, Woo SH. Individual participant data meta-analysis of primary laryngeal lymphoma: focusing on the clinical characteristics and prognosis. Laryngoscope 125:2741-2748, 2015.","DOI":"10.1002\/lary.25391"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hong SA, Tajudeen BA, Choi S, Husain IA. Epidemiology and prognostic indicators in laryngeal lymphoma: a population-based analysis. Laryngoscope 128:2044-2049, 2018.","DOI":"10.1002\/lary.27074"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Khanlari M, Chapman JR. Follicular lymphoma: updates for pathologists. J Pathol Transl Med 56:1-15, 2022.","DOI":"10.4132\/jptm.2021.09.29"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Siddiqui NA, Branstetter BF 4th, Hamilton BE. Imaging characteristics of primary laryngeal lymphoma. AJNR Am J Neuroradiol 31:1261-1265, 2010.","DOI":"10.3174\/ajnr.A2085"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Dreyling M, Ghielmini M, Rule S, Salles G, Vitolo U, Ladetto M. Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 32:298-308, 2021.","DOI":"10.1016\/j.annonc.2020.11.008"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Wirth A, Mikhaeel NG, Aleman BMP, et al. Involved site radiation therapy in adult lymphomas: an overview of International Lymphoma Radiation Oncology Group guidelines. Int J Radiat Oncol Biol Phys 107:909-933, 2020.","DOI":"10.1016\/j.ijrobp.2020.03.019"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Hoskin PJ, Kirkwood AA, Popova B, et al. 4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FoRT): a randomised phase 3 non-inferiority trial. Lancet Oncol 15:457-463, 2014.","DOI":"10.1016\/S1470-2045(14)70036-1"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hoskin P, Popova B, Schofield O, et al. 4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial. Lancet Oncol 202;22:332-340, 2021.","DOI":"10.1016\/S1470-2045(20)30686-0"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7631-26\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T04:10:45Z","timestamp":1787371845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7631-26\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":10,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7631-26","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"7631-26"}}